ATC code: A07AA02, D01AA01, G01AA01, G01AF01
Published controlled studies on differences between men and women in effect, safety and pharmacokinetics of nystatin are lacking.
No studies with a clinically relevant sex analysis regarding the pharmacokinetics or dosing of nystatin have been found.
No studies with a clinically relevant sex analysis regarding the effects of nystatin have been found.
No studies with a clinically relevant sex analysis regarding adverse effects of nystatin have been found.
Regarding teratogenic aspects, please consult Janusmed Drugs and Birth Defects (in Swedish, Janusmed fosterpåverkan).
In some countries, nystatin is available as vaginal preparations. They may damage latex contraceptives and thus additional contraceptives may be needed [1].
Updated: 2020-08-28
Date of litterature search: 2015-06-02
Reviewed by: Mia von Euler
Approved by: Karin Schenck-Gustafsson